Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Ovary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Early research (Phase 1)WithdrawnNCT02833506
What this trial is testing

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+18 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00002931
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
City of Hope Medical Center 48
Large-scale testing (Phase 3)WithdrawnNCT03905902
What this trial is testing

DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Carcinoma
SOTIO a.s.
Large-scale testing (Phase 3)Study completedNCT00113607
What this trial is testing

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 672
Not applicableNot Yet RecruitingNCT06070285
What this trial is testing

Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients

Who this might be right for
Recurrent Ovarian Cancer
Power Life Sciences Inc. 500
Early research (Phase 1)Study completedNCT02195973
What this trial is testing

Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
University of Alabama at Birmingham 15
Testing effectiveness (Phase 2)Looking for participantsNCT06873555
What this trial is testing

DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors

Who this might be right for
Solid TumorsOvarian CancerSmall Cell Lung Cancer
Heronova Pharmaceuticals 60
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00526149
What this trial is testing

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Who this might be right for
Breast CancerEndometrial CancerHead and Neck Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 76
Testing effectiveness (Phase 2)Study completedNCT02098343
What this trial is testing

P53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Who this might be right for
Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
Aprea Therapeutics 247
Testing effectiveness (Phase 2)Study completedNCT00003778
What this trial is testing

Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma

Who this might be right for
Ovarian CancerSarcoma
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)UnknownNCT01650376
What this trial is testing

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian CancerUterine Cancer
Swedish Medical Center 52
Not applicableUnknownNCT00601406
What this trial is testing

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+7 more
The Christie NHS Foundation Trust 2,200
Early research (Phase 1)Study completedNCT00003704
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

Who this might be right for
Cancer
Alliance for Clinical Trials in Oncology 51
Testing effectiveness (Phase 2)UnknownNCT00075543
What this trial is testing

Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Ended earlyNCT01296035
What this trial is testing

Panitumumab and Gemcitabine in Relapsed Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Women and Infants Hospital of Rhode Island 8
Testing effectiveness (Phase 2)WithdrawnNCT01982487
What this trial is testing

Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission

Who this might be right for
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer+30 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00231855
What this trial is testing

Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

Who this might be right for
Ovarian NeoplasmsUterine Neoplasms
Montefiore Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT03989336
What this trial is testing

The Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
Chinese PLA General Hospital 84
Next Page